Base award. Non-clinical adme studies. POP: 09/19/2016 - 09/18/2021. N01DA-16-8931.
Ended Definitive Contract Awarded Last action
- Contract number
- HHSN271201600037C
- Awardee
-
Sri International UEI SRG2J1WS9X63
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Obligated
- $489,891
Award facts
- Opportunity
-
- HHSN271201600037C Solicitation number
- Non-Clinical ADME Studies Award Notice · Posted Mar 15, 2016
- Contract value 13% obligated
-
- $489,891.25 Current, with exercised options
- $3,698,818.25 Potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541712 Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 3 offers Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Menlo Park, CA 94025, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | -$56,851 | |
| Funding Only Action | $25,458 | |
| Funding Only Action | $110,249 | |
| Funding Only Action | $86,049 | |
| Funding Only Action | $33,913 | |
| Funding Only Action | $29,108 | |
| Supplemental Agreement for work within scope | $63,035 | |
| Supplemental Agreement for work within scope | $27,954 | |
| Original award | $170,976 |
About this award
This is a Cost Plus Fixed Fee definitive contract awarded by the National Institute on Drug Abuse (NIDA), a component of the Department of Health and Human Services, to SRI International, a non-profit research institute. The $3,698,818.25 contract is for non-clinical absorption, distribution, metabolism, and excretion (ADME) studies, with a period of performance from September 19, 2016 to September 18, 2021. This award does not have a small business set-aside. SRI International, as the prime contractor, will be conducting this research and development work for NIDA, which is focused on advancing drug discovery and development. SRI International has extensive experience supporting biomedical research and development projects for federal agencies through both contracts and grants.
Quick answers
Who was awarded contract HHSN271201600037C?
HHSN271201600037C was awarded to Sri International by National Institute on Drug Abuse (National Institutes of Health) on September 19, 2016.
How much is contract HHSN271201600037C worth?
The government has obligated $489,891 on HHSN271201600037C. Its potential value, with all options, is $3,698,818.
Was contract HHSN271201600037C competed?
The extent of competition for HHSN271201600037C was full and open competition. The government received 3 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award